Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

India flag India · Delayed Price · Currency is INR
395.65
-2.45 (-0.62%)
Jun 23, 2025, 9:30 AM IST
53.57%
Market Cap 36.50B
Revenue (ttm) 13.56B
Net Income (ttm) 1.61B
Shares Out 91.67M
EPS (ttm) 17.56
PE Ratio 22.67
Forward PE 18.63
Dividend 4.50 (1.13%)
Ex-Dividend Date Sep 13, 2024
Volume 20,090
Average Volume 178,000
Open 397.05
Previous Close 398.10
Day's Range 390.55 - 399.65
52-Week Range 232.50 - 572.00
Beta 0.59
RSI 40.97
Earnings Date Jul 31, 2025

About NSE:INDRAMEDCO

Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, ... [Read more]

Sector Healthcare
Founded 1983
Employees 2,977
Stock Exchange National Stock Exchange of India
Ticker Symbol INDRAMEDCO
Full Company Profile

Financial Performance

In 2024, NSE:INDRAMEDCO's revenue was 13.56 billion, an increase of 8.97% compared to the previous year's 12.45 billion. Earnings were 1.61 billion, an increase of 29.87%.

Financial Statements

News

There is no news available yet.